Meta-analysis links elevated CRP, IL-6, serotonin, gut bacteria, and reduced oxytocin, iron to Autism Spectrum Disorder
Background
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition significantly impacting children's health, with limited effective pharmacological treatments. Emerging evidence points to a crucial role for the gut-brain axis, neuroinflammation, and specific neurochemical imbalances in its pathophysiology. However, a comprehensive understanding of how microbial factors, trace elements, and biological markers collectively contribute to ASD's clinical presentation remains a critical gap. This meta-analysis aimed to synthesize existing data to clarify these associations, providing a clearer picture of the systemic biological alterations in children with ASD.
Study Design
Researchers conducted a meta-analysis synthesizing data from 27 studies published between 2014 and 2024, involving a total of 2557 children. Data was collected from major databases including PubMed, Cochrane Library, OVID, Google Scholar, and Embase. A continuous model, employing either fixed or random effects, was utilized to calculate mean differences (MD) with 95% confidence intervals (CIs) for various microbiological variables, trace elements, and biological markers. The primary objective was to compare these indicators between children diagnosed with Autism Spectrum Disorder and neurotypical control groups.
Results
The meta-analysis revealed several significant differences in biological markers and microbial factors in children with Autism Spectrum Disorder compared to controls. Inflammatory markers were notably elevated, with C-reactive protein (CRP) showing a MD of 1.25 (95% CI, 0.11–2.39, P=0.03) and interleukin 6 (IL-6) at a MD of 2.80 (95%CI, 1.13-4.46, P=0.001). Neurotransmitter imbalances were also evident, as serotonin levels were significantly higher (MD, 111.92; 95%CI, 63.75-160.09, P<0.001). Conversely, oxytocin levels were markedly lower (MD, -53.24; 95% CI, -73.39–-33.09, P<0.001). Gut microbiota composition also differed, with increased abundance of specific bacteria:
Faecalibacteriumshowed a MD of 0.48 (95%CI: 0.29-0.66, P<0.001), andParabacteroideshad a MD of 0.20 (95%CI: 0.14-0.26, P<0.001). Furthermore, serum iron levels were significantly reduced (MD, -5.78; 95% CI, -9.43–-2.13, P=0.002) in children with ASD.
Key Findings
- C-reactive protein (CRP) was significantly higher in ASD children (MD, 1.25, P=0.03).
- Interleukin 6 (
IL-6) levels were significantly elevated in ASD children (MD, 2.80, P=0.001). - Serotonin levels were significantly higher in ASD children (MD, 111.92, P<0.001).
- Oxytocin levels were significantly lower in ASD children (MD, -53.24, P<0.001).
- Increased
Faecalibacterium(MD, 0.48, P<0.001) andParabacteroides(MD, 0.20, P<0.001) were found in ASD children. - Serum iron levels were significantly lower in ASD children (MD, -5.78, P=0.002).
Why It Matters
This meta-analysis significantly strengthens the evidence for specific biological and microbial alterations associated with Autism Spectrum Disorder. The consistent findings across multiple studies highlight potential diagnostic biomarkers and therapeutic targets beyond current standard-of-care approaches. For clinicians and researchers, these results suggest that strategies targeting chronic inflammation (e.g., anti-inflammatory interventions), modulating the gut microbiota (e.g., probiotics, prebiotics, dietary changes), addressing iron deficiency, or exploring oxytocin supplementation could be relevant avenues for future research. While these are associations and not direct causation, identifying these consistent patterns moves us closer to personalized interventions. This work underscores the importance of a multi-faceted approach to understanding and potentially managing ASD, integrating gut health, immune function, and neurochemical balance. Further research is needed to translate these findings into usable clinical protocols.
autism spectrum disorder
meta-analysis
inflammation
gut microbiota
serotonin
oxytocin